1-4 of 4
Michael C. Bassik
Close
Sort by
Journal Articles

Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia

Karina A. Kruth, Mimi Fang, Dawne N. Shelton, Ossama Abu-Halawa, Ryan Mahling, Hongxing Yang, Jonathan S. Weissman, Mignon L. Loh, Markus Müschen, Sarah K. Tasian, Michael C. Bassik, Martin Kampmann, Miles A. Pufall
Journal: Blood
Blood (2017) 129 (22): 3000–3008.
https://doi.org/10.1182/blood-2017-02-766204
Published: 2017
Includes: Supplemental data
Journal Articles

The Salicylamide Derivative, Niclosamide, Inhibits CREB Function in Acute Myeloid Leukemia Cells In Vitro and In Vivo

Hee-Don Chae, PhD, Nick Cox, PhD, Xiaohua Zhang, Jae Wook Lee, MD PhD, David Morgens, Michael C Bassik, PhD, Mark Smith, PhD, Kathleen M. Sakamoto, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1647.
https://doi.org/10.1182/blood.V128.22.1647.1647
Published: 2016
Journal Articles

Oncogenic Role for the Lck/ZAP70/PLCG2 Signaling Pathway in Pre-B-ALL Pathogenesis

Jesus Duque-Afonso, MD, Michael C. Wei, MD PhD, Chiou-Hong Lin, PhD, Jue Feng, PhD, Corina Buechele, MD, Stephen Hon-Kit Wong, PhD, Michael C Bassik, PhD, Michael L. Cleary, MD
Journal: Blood
Blood (2015) 126 (23): 810.
https://doi.org/10.1182/blood.V126.23.810.810
Published: 2015
Journal Articles

Next-Generation NAMPT Inhibitors For ALL Identified By Sequential High-Throughput Phenotypic Chemical and Functional Genomic Screens

Michael C. Wei, MD, PhD, Christina J. Matheny, PhD, Michael C. Bassik, PhD, Alicia J. Donnelly, PhD, Martin Kampmann, PhD, Masayuki Iwasaki, PhD, MSC, Obdulio Piloto, PhD, David E. Solow-Cordero, PhD, Donna Bouley, DVM, PhD, Rachel E. Rau, MD, Patrick Brown, MD, Michael T. McManus, PhD, Jonathan S. Weissman, PhD, Michael L. Cleary, MD
Journal: Blood
Blood (2013) 122 (21): 171.
https://doi.org/10.1182/blood.V122.21.171.171
Published: 2013